A Clinical Study of YL205 in Patients With Advanced Solid Tumors
Public ClinicalTrials.gov record NCT06459973. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Open-label, Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of YL205 in Patients With Advanced Solid Tumors
Study identification
- NCT ID
- NCT06459973
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- MediLink Therapeutics (Suzhou) Co., Ltd.
- Industry
- Enrollment
- 252 participants
Conditions and interventions
Conditions
Interventions
- intravenous (IV) infusion Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 3, 2024
- Primary completion
- Jul 30, 2027
- Completion
- Jul 30, 2030
- Last update posted
- Dec 22, 2025
2024 – 2030
United States locations
- U.S. sites
- 11
- U.S. states
- 11
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sarah Cannon Research Institute (SCRI)- Denver | Denver | Colorado | 80218 | Recruiting |
| Yale Cancer Center | New Haven | Connecticut | 06510 | Recruiting |
| Florida Cancer Specialists - Lake Mary | Lake Mary | Florida | 32746 | Recruiting |
| Norton Cancer Institute | Louisville | Kentucky | 40241 | Recruiting |
| Washington University School of Medicine - Center for advanced Medicine | St Louis | Missouri | 63110 | Recruiting |
| Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley | Las Vegas | Nevada | 89169 | Recruiting |
| Southwest Women's Oncology | Albuquerque | New Mexico | 87109 | Recruiting |
| Stephenson Cancer Center (Oklahoma) | Oklahoma City | Oklahoma | 73104 | Recruiting |
| Providence Cancer Institute - Franz Clinic | Portland | Oregon | 97213 | Recruiting |
| Sarah Cannon Research (SCRI)-Tennessee | Nashville | Texas | 37203 | Recruiting |
| University of Washington | Seattle | Washington | 98915 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06459973, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06459973 live on ClinicalTrials.gov.